| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10751679 | Biochemical and Biophysical Research Communications | 2015 | 4 Pages |
Abstract
The PTEN increase due to TNFα treatment was reversible by both PTEN siRNA knockdown and VO-OHpic treatment. Thus, PTEN is identified as a potential new therapeutic target for reducing IR in Type 2 DM.
Keywords
FBGPVDFPPARGCDCSfMPMSFHepatocytesNFκBAdipocyteDiabetesserum free mediumPolyvinylidene fluoride membranenuclear factor kappa-light-chain-enhancer of activated B cellsphosphatase and tensin homolog deleted on chromosome 10phenylmethylsulfonyl fluoridefasting blood glucoseMEMObesityCenter for Disease ControlInsulin resistancePten
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
David A. Bulger, Jermaine Conley, Spencer H. Conner, Gipsy Majumdar, Solomon S. Solomon,